Insider Sales at Kyntra Bio: CFO & CEO Sell Shares Amid Volatile Market and Clinical Uncertainty
Insightful look at Kyntra Bio’s recent insider sales amid a shaky stock price and pending clinical data, revealing what executives’ moves mean for investors.
3 minutes to read